http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2688338-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ae6dd5bafbd2dd69035367385d754c |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-00 |
filingDate | 2019-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55d83dde94060ac399529164fd38fb57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6f873d1d6f4fd8f84f014df080b4611 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_637620d5e94b4d05699f36c6bf9162b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e37b673baf8488c309fcdb7d18c880c4 |
publicationDate | 2019-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2688338-C1 |
titleOfInvention | Method for predicting effectiveness of transcranial magnetic stimulation of brain in treating patients with depressive disorders |
abstract | FIELD: medicine. n SUBSTANCE: invention refers to psychiatry and neurophysiology, and can be used in predicting the effectiveness of transcranial magnetic cerebral stimulation in treating patients with depressive disorders with psychopharmacotherapy inefficiency. That is ensured by recording electroencephalography in leads along the cortical areas of regions of the right and left cerebral hemispheres. Performing coherent analysis of alpha rhythm. A coherence index is calculated in each cortical zone with subsequent calculation of arithmetic coherence index of all cortical zones. If the arithmetic coherence index is more than 0.35 in all cortical areas, a positive effect of the transcranial magnetic stimulation of the brain in treating the patients with depressive disorders is predicted. n EFFECT: method provides the EEG parameters calculation accuracy and validity of the therapeutic approach selection using transcranial magnetic stimulation in the given patients. n 1 cl, 3 tbl, 3 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2723607-C1 |
priorityDate | 2019-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.